BRPI0206904B8 - métodos de quantificação de proteína glicada em uma amostra, de quantificação da quantidade de proteína glicada em uma amostra biológica, de quantificação da hemoglobina glicada em uma amostra de sangue, e de quantificação de proteína glicada que não é hemoglobina em uma amostra biológica - Google Patents

métodos de quantificação de proteína glicada em uma amostra, de quantificação da quantidade de proteína glicada em uma amostra biológica, de quantificação da hemoglobina glicada em uma amostra de sangue, e de quantificação de proteína glicada que não é hemoglobina em uma amostra biológica

Info

Publication number
BRPI0206904B8
BRPI0206904B8 BRPI0206904A BR0206904A BRPI0206904B8 BR PI0206904 B8 BRPI0206904 B8 BR PI0206904B8 BR PI0206904 A BRPI0206904 A BR PI0206904A BR 0206904 A BR0206904 A BR 0206904A BR PI0206904 B8 BRPI0206904 B8 BR PI0206904B8
Authority
BR
Brazil
Prior art keywords
quantifying
glycated
sample
glycated protein
hemoglobin
Prior art date
Application number
BRPI0206904A
Other languages
English (en)
Other versions
BRPI0206904B1 (pt
BR0206904A (pt
Inventor
E Melton Cameron
P Mccroskey Ralph
Original Assignee
Scripps Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Laboratories filed Critical Scripps Laboratories
Publication of BR0206904A publication Critical patent/BR0206904A/pt
Publication of BRPI0206904B1 publication Critical patent/BRPI0206904B1/pt
Publication of BRPI0206904B8 publication Critical patent/BRPI0206904B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"métodos e dispositivos para quantificação de proteína com glicato". a presente invenção refere-se a métodos para quantificação de proteínas com glicato em uma amostra biológica usando uma matriz de suporte sólido fazendo uma primeira medição de proteína ligada sob condições onde ambas as proteínas com glicato e sem glicato se ligam na suporte e fazendo uma segunda medição de proteína ligada sob condições onde a proteína com glicato é ligada ao suporte e a proteína sem glicato não é substancialmente ligada. dispositivos de diagnósticos e conjuntos compreendendo os métodos da presente invenção são também proporcionados.
BRPI0206904A 2001-01-31 2002-01-31 métodos de quantificação de proteína glicada em uma amostra, de quantificação da quantidade de proteína glicada em uma amostra biológica, de quantificação da hemoglobina glicada em uma amostra de sangue, e de quantificação de proteína glicada que não é hemoglobina em uma amostra biológica BRPI0206904B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26522901P 2001-01-31 2001-01-31
US6228102A 2002-01-30 2002-01-30
PCT/US2002/002891 WO2002061436A1 (en) 2001-01-31 2002-01-31 Methods and devices for quantitation of glycated protein

Publications (3)

Publication Number Publication Date
BR0206904A BR0206904A (pt) 2004-06-01
BRPI0206904B1 BRPI0206904B1 (pt) 2016-08-30
BRPI0206904B8 true BRPI0206904B8 (pt) 2021-07-27

Family

ID=26742069

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0206904A BRPI0206904B8 (pt) 2001-01-31 2002-01-31 métodos de quantificação de proteína glicada em uma amostra, de quantificação da quantidade de proteína glicada em uma amostra biológica, de quantificação da hemoglobina glicada em uma amostra de sangue, e de quantificação de proteína glicada que não é hemoglobina em uma amostra biológica

Country Status (10)

Country Link
EP (1) EP1360505B1 (pt)
JP (1) JP4392164B2 (pt)
CN (1) CN1489693B (pt)
AT (1) ATE392621T1 (pt)
BR (1) BRPI0206904B8 (pt)
CA (1) CA2435741C (pt)
DE (1) DE60226125T2 (pt)
IL (2) IL157047A0 (pt)
MX (1) MXPA03006838A (pt)
WO (1) WO2002061436A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008016193A1 (en) * 2006-07-29 2008-02-07 I-Sens, Inc. Electrochemical determination system of glycated proteins
CN101493467A (zh) * 2008-01-25 2009-07-29 上海伊思柏生物科技有限公司 定量测定糖化蛋白质的方法
JP5015973B2 (ja) * 2009-01-30 2012-09-05 日立アロカメディカル株式会社 抗原の検出方法
CA2799996C (en) * 2009-05-20 2018-01-02 Relia Diagnostic Systems, Inc. Systems and methods for determining the percentage of glycated hemoglobin
WO2014025715A2 (en) * 2012-08-08 2014-02-13 Paul Saunders Compact multiple media chromatography
WO2014184810A1 (en) * 2013-05-15 2014-11-20 Council Of Scientific & Industrial Research Method for assaying glycated protein
WO2015157669A1 (en) * 2014-04-11 2015-10-15 Siemens Healthcare Diagnostics Inc. Spectroscopic methods for the detection of glycated hemoglobin
KR102111937B1 (ko) * 2015-11-18 2020-05-19 라디오미터 메디컬 에이피에스 유체 중 피분석물의 광학 검출을 위한 다공성 미러
CN108070634B (zh) * 2017-11-24 2021-04-06 宁波美康保生生物医学工程有限公司 糖尿病三项联合检测试剂盘
CN109540846B (zh) * 2019-01-04 2022-04-12 无锡博慧斯生物医药科技有限公司 一种测量糖化的蛋白质的方法
CN110967488B (zh) * 2019-12-20 2023-04-07 深圳优迪生物技术有限公司 试纸条、试剂盒以及测定糖化血红蛋白的方法
CN115541893B (zh) * 2021-06-30 2023-10-24 无锡博慧斯生物医药科技有限公司 糖化检测卡膜处理方法
CN115825293B (zh) * 2023-02-21 2023-10-13 艾康生物技术(杭州)有限公司 一种用于糖化血红蛋白测试的试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024829B (en) * 1978-06-28 1982-08-04 Amicon Corp Method and product for separation of glycoproteins
DE3720736A1 (de) * 1987-06-23 1989-01-05 Erwin Dr Schleicher Verfahren, reagenzien und ausruestung zur einfachen bestimmung von nicht-enzymatisch glykosylierten proteinen in koerperfluessigkeiten
GB9024771D0 (en) * 1990-11-14 1991-01-02 Axis Research Assay
US6162645A (en) * 1997-03-13 2000-12-19 Abbott Laboratories Determination of % glycated hemoglobin

Also Published As

Publication number Publication date
EP1360505B1 (en) 2008-04-16
CN1489693A (zh) 2004-04-14
CA2435741A1 (en) 2002-08-08
BRPI0206904B1 (pt) 2016-08-30
CN1489693B (zh) 2010-04-28
WO2002061436A8 (en) 2004-06-03
WO2002061436A1 (en) 2002-08-08
EP1360505A1 (en) 2003-11-12
ATE392621T1 (de) 2008-05-15
IL157047A (en) 2010-04-29
DE60226125D1 (de) 2008-05-29
MXPA03006838A (es) 2004-10-15
JP2004532388A (ja) 2004-10-21
JP4392164B2 (ja) 2009-12-24
IL157047A0 (en) 2004-02-08
DE60226125T2 (de) 2009-05-07
BR0206904A (pt) 2004-06-01
CA2435741C (en) 2011-05-31

Similar Documents

Publication Publication Date Title
BRPI0206904B8 (pt) métodos de quantificação de proteína glicada em uma amostra, de quantificação da quantidade de proteína glicada em uma amostra biológica, de quantificação da hemoglobina glicada em uma amostra de sangue, e de quantificação de proteína glicada que não é hemoglobina em uma amostra biológica
BRPI0518994A2 (pt) anticorpos ou polipeptÍdeos que se ligam a br3, seus usos e formulaÇÕes lÍquidas
EP1967595A3 (en) Parallel genotyping of multiple patient samples
EP1687283A4 (en) PROCESS AND COMPOSITION FOR DETERMINING FK 506
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
NO20060236L (no) Antistoffer spesifikke for sklerostinro og fremgangsmate for a oke benmineralisering
DE69738739D1 (de) Verfahren für das Entwerfen von kleinen Erythropoietin Mimetika
HUP0202532A2 (hu) Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása
NO20045294L (no) Assey for glykosylerte proteiner
DE60211651D1 (de) Proteom-analyseverfahren
BRPI0416922A (pt) composições e métodos para medição de concentrações de analito
ATE474228T1 (de) Reagenz für hämoglobinabbau
Cleland Solid digestion of demineralized bone as a method to access potentially insoluble proteins and post-translational modifications
ES2194116T3 (es) Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.
NO20050130L (no) Bakteriell testmetode ved glykatert merket binding
ATE299589T1 (de) Verfahren zur bestimmung von substanzen mittels der evaneszenzfeldmethode
WO2002035228A3 (de) Verfahren und testkit zum nachweis von analyten in einer probe
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
DE60140346D1 (de) System zur internen, qualitativen und quantitativen überprüfung von zellmarker-indices
ATE313799T1 (de) Nachweis von hla-g
BR0010259A (pt) Método para caracterização de células, kit, e, aparelho para executar análise de par‰metro único ou de múltiplos par‰metros em uma suspensão de células
WO2004078783A3 (en) Enzymes involved in apoptosis
DE60231845D1 (de) Diagnoseverfahren für proteinprofilierung
ATE489634T1 (de) In vitro methode zur klinischen diagnose.
WO2023114515A3 (en) Anti-pilra antibodies, uses thereof, and related methods and reagents

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/08/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/01/2002, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 31/01/2022